Clinical trial
Construction and Clinical Validation of a Predictive Model for Postoperative Adjuvant Therapy in Hepatocellular Carcinoma Based on Whole-Slide Digital Pathological Images and Deep Learning
NCT07417800 is registered in ClinicalTrials.gov with Second Affiliated Hospital, Zhejiang University, School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Construction and Clinical Validation of a Predictive Model for Postoperative Adjuvant Therapy in Hepatocellular Carcinoma Based on Whole-Slide Digital Pathological Images and Deep Learning
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 1, 2025
- Completion date
- December 1, 2029
- Enrollment
- 11,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adjuvant chemoradiotherapy, artificial intelligent, hepatocellular carcinoma (hcc), lenvatinib, liver surgery, tace